AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, has formalised a new partnership with BioNSW, a rapidly growing not-for-profit organisation dedicated to harnessing the full potential of the New South Wales Life Sciences sector.

The signing of this Memorandum of Understanding (MoU) represents a significant step forward in promoting a connected and thriving biotechnology ecosystem across NSW and beyond. 

The partnership underscores a shared commitment to catalysing innovation, investment, and skills development across the sector. Together, AusBiotech and BioNSW will work to amplify the strengths of NSW’s biotechnology industry, accelerating cross-sector collaboration and promoting growth.   

Rebekah Cassidy, CEO of AusBiotech, stated, “My consistent message has been that, as the leading national advocate, we have a responsibility to collaborate and deepen our relationships with our partners in each of the states, including New South Wales. Through our own thriving membership, we know that NSW's biotech and medtech community is exciting and strong. Coordinating locally and nationally to foster joint advocacy is a critical enabler for the future of our sector. Unifying the sector's voice must be one of our most critical, shared priorities.”  

Brad Walsh, Acting Chair and Co-Founder of BioNSW, said,“The NSW LifeSciences Sector is significant in size and importance with the largest number of Biotech companies amongst the states – with the sector having doubled in size over the last 7 years."